COVID-19 Impact on Global Direct-to-consumer Disease Risk and Health Test Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Direct-to-consumer Disease Risk and Health Test Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Celiac Disease
  • 1.4.3 Parkinson Disease
  • 1.4.4 Alzheimer Disease
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Direct-to-consumer Disease Risk and Health Test Market Share by Application: 2020 VS 2026
  • 1.5.2 Online
  • 1.5.3 Offline
• 1.6 Coronavirus Disease 2019 (Covid-19): Direct-to-consumer Disease Risk and Health Test Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Direct-to-consumer Disease Risk and Health Test Industry
    • 1.6.1.1 Direct-to-consumer Disease Risk and Health Test Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Direct-to-consumer Disease Risk and Health Test Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Direct-to-consumer Disease Risk and Health Test Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Direct-to-consumer Disease Risk and Health Test Market Perspective (2015-2026)
• 2.2 Direct-to-consumer Disease Risk and Health Test Growth Trends by Regions
  • 2.2.1 Direct-to-consumer Disease Risk and Health Test Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Direct-to-consumer Disease Risk and Health Test Historic Market Share by Regions (2015-2020)
  • 2.2.3 Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Direct-to-consumer Disease Risk and Health Test Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Direct-to-consumer Disease Risk and Health Test Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Market Size
  • 3.1.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue (2015-2020)
  • 3.1.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Direct-to-consumer Disease Risk and Health Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio
  • 3.2.1 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Direct-to-consumer Disease Risk and Health Test Revenue in 2019
• 3.3 Direct-to-consumer Disease Risk and Health Test Key Players Head office and Area Served
• 3.4 Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
• 3.5 Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Type (2015-2020)
• 4.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2021-2026)

5 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Application (2015-2026)

• 5.1 Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
• 5.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
• 6.2 Direct-to-consumer Disease Risk and Health Test Key Players in North America (2019-2020)
• 6.3 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
• 6.4 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
• 7.2 Direct-to-consumer Disease Risk and Health Test Key Players in Europe (2019-2020)
• 7.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
• 7.4 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)

8 China

• 8.1 China Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
• 8.2 Direct-to-consumer Disease Risk and Health Test Key Players in China (2019-2020)
• 8.3 China Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
• 8.4 China Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
• 9.2 Direct-to-consumer Disease Risk and Health Test Key Players in Japan (2019-2020)
• 9.3 Japan Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
• 9.4 Japan Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
• 10.2 Direct-to-consumer Disease Risk and Health Test Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
• 10.4 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)

11 India

• 11.1 India Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
• 11.2 Direct-to-consumer Disease Risk and Health Test Key Players in India (2019-2020)
• 11.3 India Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
• 11.4 India Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
• 12.2 Direct-to-consumer Disease Risk and Health Test Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
• 12.4 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 23andMe
  • 13.1.1 23andMe Company Details
  • 13.1.2 23andMe Business Overview and Its Total Revenue
  • 13.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.1.4 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020))
  • 13.1.5 23andMe Recent Development
• 13.2 MyHeritage
  • 13.2.1 MyHeritage Company Details
  • 13.2.2 MyHeritage Business Overview and Its Total Revenue
  • 13.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.2.4 MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.2.5 MyHeritage Recent Development
• 13.3 LabCorp
  • 13.3.1 LabCorp Company Details
  • 13.3.2 LabCorp Business Overview and Its Total Revenue
  • 13.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.3.4 LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.3.5 LabCorp Recent Development
• 13.4 Myriad Genetics
  • 13.4.1 Myriad Genetics Company Details
  • 13.4.2 Myriad Genetics Business Overview and Its Total Revenue
  • 13.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.4.4 Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.4.5 Myriad Genetics Recent Development
• 13.5 Ancestry.com
  • 13.5.1 Ancestry.com Company Details
  • 13.5.2 Ancestry.com Business Overview and Its Total Revenue
  • 13.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.5.4 Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.5.5 Ancestry.com Recent Development
• 13.6 Quest Diagnostics
  • 13.6.1 Quest Diagnostics Company Details
  • 13.6.2 Quest Diagnostics Business Overview and Its Total Revenue
  • 13.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.6.4 Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.6.5 Quest Diagnostics Recent Development
• 13.7 Gene By Gene
  • 13.7.1 Gene By Gene Company Details
  • 13.7.2 Gene By Gene Business Overview and Its Total Revenue
  • 13.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.7.4 Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.7.5 Gene By Gene Recent Development
• 13.8 DNA Diagnostics Center
  • 13.8.1 DNA Diagnostics Center Company Details
  • 13.8.2 DNA Diagnostics Center Business Overview and Its Total Revenue
  • 13.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.8.5 DNA Diagnostics Center Recent Development
• 13.9 Invitae
  • 13.9.1 Invitae Company Details
  • 13.9.2 Invitae Business Overview and Its Total Revenue
  • 13.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.9.4 Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.9.5 Invitae Recent Development
• 13.10 IntelliGenetics
  • 13.10.1 IntelliGenetics Company Details
  • 13.10.2 IntelliGenetics Business Overview and Its Total Revenue
  • 13.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Introduction
  • 13.10.4 IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 13.10.5 IntelliGenetics Recent Development
• 13.11 Ambry Genetics
  • 10.11.1 Ambry Genetics Company Details
  • 10.11.2 Ambry Genetics Business Overview and Its Total Revenue
  • 10.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.11.4 Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.11.5 Ambry Genetics Recent Development
• 13.12 Living DNA
  • 10.12.1 Living DNA Company Details
  • 10.12.2 Living DNA Business Overview and Its Total Revenue
  • 10.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.12.4 Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.12.5 Living DNA Recent Development
• 13.13 EasyDNA
  • 10.13.1 EasyDNA Company Details
  • 10.13.2 EasyDNA Business Overview and Its Total Revenue
  • 10.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.13.4 EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.13.5 EasyDNA Recent Development
• 13.14 Pathway Genomics
  • 10.14.1 Pathway Genomics Company Details
  • 10.14.2 Pathway Genomics Business Overview and Its Total Revenue
  • 10.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.14.4 Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.14.5 Pathway Genomics Recent Development
• 13.15 Centrillion Technology
  • 10.15.1 Centrillion Technology Company Details
  • 10.15.2 Centrillion Technology Business Overview and Its Total Revenue
  • 10.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.15.4 Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.15.5 Centrillion Technology Recent Development
• 13.16 Xcode
  • 10.16.1 Xcode Company Details
  • 10.16.2 Xcode Business Overview and Its Total Revenue
  • 10.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.16.4 Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.16.5 Xcode Recent Development
• 13.17 Color Genomics
  • 10.17.1 Color Genomics Company Details
  • 10.17.2 Color Genomics Business Overview and Its Total Revenue
  • 10.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.17.4 Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.17.5 Color Genomics Recent Development
• 13.18 Anglia DNA Services
  • 10.18.1 Anglia DNA Services Company Details
  • 10.18.2 Anglia DNA Services Business Overview and Its Total Revenue
  • 10.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.18.4 Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.18.5 Anglia DNA Services Recent Development
• 13.19 African Ancestry
  • 10.19.1 African Ancestry Company Details
  • 10.19.2 African Ancestry Business Overview and Its Total Revenue
  • 10.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.19.4 African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.19.5 African Ancestry Recent Development
• 13.20 Canadian DNA Services
  • 10.20.1 Canadian DNA Services Company Details
  • 10.20.2 Canadian DNA Services Business Overview and Its Total Revenue
  • 10.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.20.4 Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.20.5 Canadian DNA Services Recent Development
• 13.21 DNA Family Check
  • 10.21.1 DNA Family Check Company Details
  • 10.21.2 DNA Family Check Business Overview and Its Total Revenue
  • 10.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.21.4 DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.21.5 DNA Family Check Recent Development
• 13.22 Alpha Biolaboratories
  • 10.22.1 Alpha Biolaboratories Company Details
  • 10.22.2 Alpha Biolaboratories Business Overview and Its Total Revenue
  • 10.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.22.5 Alpha Biolaboratories Recent Development
• 13.23 Test Me DNA
  • 10.23.1 Test Me DNA Company Details
  • 10.23.2 Test Me DNA Business Overview and Its Total Revenue
  • 10.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.23.4 Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.23.5 Test Me DNA Recent Development
• 13.24 23 Mofang
  • 10.24.1 23 Mofang Company Details
  • 10.24.2 23 Mofang Business Overview and Its Total Revenue
  • 10.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.24.4 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.24.5 23 Mofang Recent Development
• 13.25 Genetic Health
  • 10.25.1 Genetic Health Company Details
  • 10.25.2 Genetic Health Business Overview and Its Total Revenue
  • 10.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.25.4 Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.25.5 Genetic Health Recent Development
• 13.26 DNA Services of America
  • 10.26.1 DNA Services of America Company Details
  • 10.26.2 DNA Services of America Business Overview and Its Total Revenue
  • 10.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.26.4 DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.26.5 DNA Services of America Recent Development
• 13.27 Shuwen Health Sciences
  • 10.27.1 Shuwen Health Sciences Company Details
  • 10.27.2 Shuwen Health Sciences Business Overview and Its Total Revenue
  • 10.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.27.5 Shuwen Health Sciences Recent Development
• 13.28 Mapmygenome
  • 10.28.1 Mapmygenome Company Details
  • 10.28.2 Mapmygenome Business Overview and Its Total Revenue
  • 10.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.28.4 Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.28.5 Mapmygenome Recent Development
• 13.29 Full Genomes
  • 10.29.1 Full Genomes Company Details
  • 10.29.2 Full Genomes Business Overview and Its Total Revenue
  • 10.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Introduction
  • 10.29.4 Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
  • 10.29.5 Full Genomes Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer